logo

Last Update

This profile was last updated on 12/20/2016 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Banu Zolnik?

Banu Sizanli Zolnik

Pharmacologist

Food and Drug Administration

HQ Phone:  (301) 827-6500

Direct Phone: (301) ***-****direct phone

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Food and Drug Administration

5600 Fishers Lane

Rockville, Maryland,20852

United States

Company Description

China's Food and Drug Administration (SFDA) is now offering a reward of about 50,000 US dollars for relevant information on counterfeit drug production. The bounty aims to "encourage the public to report illegal activities so as to determine, control and elimi...more

Background Information

Employment History

Biopharmaceutics Reviewer In the Division of Biopharmaceutics, Office

New Drug Products


Affiliations

National Cancer Institute

Postdoctoral Fellow


Education

B.S. degree

Pharmacy

Istanbul University


Ph.D.


doctorate

Pharmaceutical Sciences

The University of Connecticut


Web References(2 Total References)


REdI Faculty | SBIA Events

sbiaevents.com [cached]

Banu Sizanli Zolnik, PhD
Division of Biopharmaceutics, Office of New Drug Products (ONDP), Office of Product Quality (OPQ), CDER, FDA Banu Sizanli Zolnik is a biopharmaceutics reviewer in the Division of Biopharmaceutics, Office of New Drug Products within the Office of Product Quality (OPQ) at the FDA. Her responsibilities are to evaluate and review biopharmaceutics section of the New Drug Applications (NDAs) and drug component of the drug-device combination products. Upon the inception of the OQP in January 2015, Dr. Zolnik also evaluates and reviews the dissolution method for Abbreviated New Drug Applications (ANDAs). Previously, she was involved in various regulatory science policy projects related to nanotechnology, bioequivalence of generic drugs and drug product quality issues in the Science and Research Staff (SRS) of the Office of Pharmaceutical Science. Prior to joining SRS, Dr. Zolnik was a bioequivalence reviewer at the Office of Generic Drugs. Prior to joining FDA, she was a post-doctoral fellow in the Nanotechnology ChaRACterization Laboratory/NIH. Dr. Zolnik obtained her doctorate in Pharmaceutical Sciences from the University of Connecticut and a BS degree in Pharmacy from Istanbul University.


Generic Drugs Forum 2015 Files | SBIA Events

sbiaevents.com [cached]

Banu Sizanli Zolnik, Ph.D.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory